Media is the fastest growing segment, North America is the largest regional market
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
Advancements in regenerative medicine and cell and gene therapies represent a significant driver for the global biopreservation market, necessitating sophisticated methods to preserve delicate biological materials. The expansion of these therapeutic areas, offering novel treatments for previously intractable diseases, directly fuels the demand for high-quality preservation and storage solutions for cells, tissues, and genetic constructs. These innovative therapies rely heavily on maintaining the viability and integrity of living cells from research to clinical application. According to the Alliance for Regenerative Medicine, in 2024, investments in the cell and gene therapy sector reached $15.2 billion, demonstrating a 30% growth compared to 2023. This substantial financial commitment underscores the escalating pipeline of therapies requiring robust biopreservation infrastructure.Key Market Challenges
The challenging factor explicitly identified in the overview is the substantial cost associated with advanced biopreservation techniques and specialized equipment. This significant financial burden directly impedes the growth of the Global Bio Preservation Market by presenting considerable barriers to both initial setup and sustained operation for many organizations. The high cost encompasses the acquisition of specialized equipment, such as ultra-low temperature freezers and advanced cryopreservation systems, along with recurring expenses for liquid nitrogen, cryoprotective agents, and highly skilled personnel. Such extensive investment demands often exceed the budgetary allocations of smaller research institutions, emerging biobanks, and even some larger entities.Key Market Trends
The integration of Artificial Intelligence (AI) is a pivotal trend transforming the Global Bio Preservation Market by optimizing complex processes and enhancing sample integrity. AI algorithms analyze extensive datasets from cryopreservation protocols and post-preservation viability, identifying optimal conditions and predicting outcomes, thereby refining preservation methodologies. For instance, according to The University of Manchester, in September 2024, scientists developing a machine learning program for cryoprotectant discovery reduced the amount of conventional cryoprotectant required for blood storage by introducing newly identified molecules. This demonstrates AI's direct impact on improving preservation techniques.Key Market Players Profiled:
- BioCision LLC
- BioLife Solutions Inc.
- ThermoGenesis Holdings, Inc.
- Custom Biogenic Systems Inc.
- Lifeline Scientific Inc.
- Merck KGaA
- Princeton CryoTech Inc.
- VWR International, LLC
- Azenta US Inc.
- Koninklijke DSM N.V.
Report Scope:
In this report, the Global Bio Preservation Market has been segmented into the following categories:By Product:
- Equipment
- Media
- LIMS
By Application:
- Regenerative Medicine
- Bio-banking
- Drug Discovery
By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bio Preservation Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
The companies profiled in this Bio Preservation market report include:- BioCision LLC
- BioLife Solutions Inc.
- ThermoGenesis Holdings, Inc.
- Custom Biogenic Systems Inc.
- Lifeline Scientific Inc.
- Merck KGaA
- Princeton CryoTech Inc.
- VWR International, LLC
- Azenta US Inc.
- Koninklijke DSM N.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | November 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.1 Billion |
| Forecasted Market Value ( USD | $ 3.7 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


